search
Back to results

Polyphenols and Overfeeding (Poly-Nut)

Primary Purpose

Overfeeding

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
2g of grape polyphenol extract
Dietary Supplement: 2g of placebo (lactose)
Sponsored by
Hospices Civils de Lyon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Overfeeding focused on measuring Overfeeding, Fat distribution, Subcutaneous and visceral adipose tissue, Insulin sensitivity, Insulin resistance, Peripheral and hepatic insulin sensitivity, Stable isotopes, Lipid oxidation, Energy expenditure, Muscle and subcutaneous adipose tissue gene expression

Eligibility Criteria

18 Years - 55 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Male
  • Aged from 18 to 55 years
  • Body Mass Index of 23 to 27 kg/m²
  • Normal blood pressure
  • Fasting glycemia < 7 mmol/L
  • CRPus < 10mg/L
  • Triglycerides ≤ 3mmol/L

Exclusion Criteria:

  • Medical or surgical history which may affect the results (renal -cardiovascular - hepatic- endocrine-inflammatory diseases)
  • Subjects under treatment which may interfere with the measured parameters
  • Eating disorder
  • Intensive sportive activity
  • Dairy products allergy or intolerance

Sites / Locations

  • Rhône Alpes Human Nutrition Center (CRNH Rhône-Alpes)

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

2g of grape polyphenol extract supplement

2g of placebo (lactose)

Arm Description

Men will have to consume daily 2g of grape polyphenol extract during the 31 days of overfeeding.

Men will have to consume daily 2g of placebo during the 31 days of overfeeding.

Outcomes

Primary Outcome Measures

Peripheral insulin sensitivity
Volunteers will have peripheral and hepatic insulin sensitivity determined by using a two-stage hyperinsulinemic euglycemic clamp with stable isotopically labeled tracer infusion.

Secondary Outcome Measures

Hepatic insulin sensitivity
Endogenous glucose production (EGP) will be determined during the last 30 minutes of the low-dose insulin infusion.
Change in genes expression in adipose and muscle tissues
RT-PCR
Anthropometry, Fat quantification and Abdominal fat distribution
Weight, height, waist and hip circumferences, fat mass using dual x-ray absorptiometry (DEXA) and abdominal fat distribution using resonance magnetic imaging (RMI).
Fasting and Postprandial partitioning of exogenous lipid
13C enrichment will be measured in blood samples and breath test during a test meal performed before and after the 31 days of overfeeding.
Modification in intestinal microbiota
Feces analyses
Energy expenditure and substrate oxidation with indirect calorimetry
Energy metabolism will be measured before and after the 31 days of overfeeding.

Full Information

First Posted
May 13, 2014
Last Updated
August 22, 2017
Sponsor
Hospices Civils de Lyon
search

1. Study Identification

Unique Protocol Identification Number
NCT02145780
Brief Title
Polyphenols and Overfeeding
Acronym
Poly-Nut
Official Title
Polyphenols: Protection From Overfeeding-induced Insulin Resistance?
Study Type
Interventional

2. Study Status

Record Verification Date
August 2017
Overall Recruitment Status
Completed
Study Start Date
February 2014 (Actual)
Primary Completion Date
May 2017 (Actual)
Study Completion Date
May 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Obesity is a complex and multifactorial disease representing a major public health challenge. Indeed, overweight and obese people carry a major risk of developing insulin resistance and type 2 diabetes mellitus. It has been demonstrated that polyphenols could be used to counteract some of the mechanisms involved in the generation of insulin resistance. The model of overfeeding represents a very good study model of the metabolic complications of obesity, since it has been shown to induce a transient state of insulin resistance in the human. The purpose of this research is to study the effects of a overfeeding (+50% of daily caloric needs over 31 days) with or without polyphenols supplementation (2g/days over 31 days) on insulin sensitivity measured in the setting of a hyperinsulinemic euglycemic clamp and on post prandial partitioning of exogenous lipids after a test meal. During 31 days, the volunteers will consume chocolate bars, chips, chocolate breads and cola in addition to their usual diet and will be supplemented with 2g of grape polyphenols extract or with placebo.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overfeeding
Keywords
Overfeeding, Fat distribution, Subcutaneous and visceral adipose tissue, Insulin sensitivity, Insulin resistance, Peripheral and hepatic insulin sensitivity, Stable isotopes, Lipid oxidation, Energy expenditure, Muscle and subcutaneous adipose tissue gene expression

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
42 (Actual)

8. Arms, Groups, and Interventions

Arm Title
2g of grape polyphenol extract supplement
Arm Type
Experimental
Arm Description
Men will have to consume daily 2g of grape polyphenol extract during the 31 days of overfeeding.
Arm Title
2g of placebo (lactose)
Arm Type
Placebo Comparator
Arm Description
Men will have to consume daily 2g of placebo during the 31 days of overfeeding.
Intervention Type
Dietary Supplement
Intervention Name(s)
2g of grape polyphenol extract
Intervention Description
Men will have to consume daily 2g of grape polyphenol extract during the 31 days of overfeeding.
Intervention Type
Dietary Supplement
Intervention Name(s)
Dietary Supplement: 2g of placebo (lactose)
Intervention Description
Men will have to consume daily 2g of placebo during the 31 days of overfeeding.
Primary Outcome Measure Information:
Title
Peripheral insulin sensitivity
Description
Volunteers will have peripheral and hepatic insulin sensitivity determined by using a two-stage hyperinsulinemic euglycemic clamp with stable isotopically labeled tracer infusion.
Time Frame
During 31 days
Secondary Outcome Measure Information:
Title
Hepatic insulin sensitivity
Description
Endogenous glucose production (EGP) will be determined during the last 30 minutes of the low-dose insulin infusion.
Time Frame
before and after the 31 days of overfeeding
Title
Change in genes expression in adipose and muscle tissues
Description
RT-PCR
Time Frame
Before and after the 31 days of overfeeding
Title
Anthropometry, Fat quantification and Abdominal fat distribution
Description
Weight, height, waist and hip circumferences, fat mass using dual x-ray absorptiometry (DEXA) and abdominal fat distribution using resonance magnetic imaging (RMI).
Time Frame
During 31 days
Title
Fasting and Postprandial partitioning of exogenous lipid
Description
13C enrichment will be measured in blood samples and breath test during a test meal performed before and after the 31 days of overfeeding.
Time Frame
Fasting and during all the postprandial period (0-300 minutes)
Title
Modification in intestinal microbiota
Description
Feces analyses
Time Frame
Before and after the 31 days of overfeeding
Title
Energy expenditure and substrate oxidation with indirect calorimetry
Description
Energy metabolism will be measured before and after the 31 days of overfeeding.
Time Frame
Fasting and during all the postprandial period (0-300 minutes)

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Male Aged from 18 to 55 years Body Mass Index of 23 to 27 kg/m² Normal blood pressure Fasting glycemia < 7 mmol/L CRPus < 10mg/L Triglycerides ≤ 3mmol/L Exclusion Criteria: Medical or surgical history which may affect the results (renal -cardiovascular - hepatic- endocrine-inflammatory diseases) Subjects under treatment which may interfere with the measured parameters Eating disorder Intensive sportive activity Dairy products allergy or intolerance
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Martine LAVILLE, MD, PhD
Organizational Affiliation
Rhône Alpes Human Nutrition Center (CRNH Rhône-Alpes)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rhône Alpes Human Nutrition Center (CRNH Rhône-Alpes)
City
Pierre-bénite
ZIP/Postal Code
69495
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
36386937
Citation
Bartova S, Madrid-Gambin F, Fernandez L, Carayol J, Meugnier E, Segrestin B, Delage P, Vionnet N, Boizot A, Laville M, Vidal H, Marco S, Hager J, Moco S. Grape polyphenols decrease circulating branched chain amino acids in overfed adults. Front Nutr. 2022 Oct 26;9:998044. doi: 10.3389/fnut.2022.998044. eCollection 2022.
Results Reference
derived
PubMed Identifier
35614978
Citation
Segrestin B, Delage P, Nemeth A, Seyssel K, Disse E, Nazare JA, Lambert-Porcheron S, Meiller L, Sauvinet V, Chanon S, Simon C, Ratiney H, Beuf O, Pralong F, Yassin NA, Boizot A, Gachet M, Burton-Pimentel KJ, Vidal H, Meugnier E, Vionnet N, Laville M. Polyphenol Supplementation Did Not Affect Insulin Sensitivity and Fat Deposition During One-Month Overfeeding in Randomized Placebo-Controlled Trials in Men and in Women. Front Nutr. 2022 May 9;9:854255. doi: 10.3389/fnut.2022.854255. eCollection 2022.
Results Reference
derived

Learn more about this trial

Polyphenols and Overfeeding

We'll reach out to this number within 24 hrs